Syngene International Ltd. announced the opening of its Centre for Advanced Protein Studies (CAPS) by the Secretary, Department of Biotechnology, Government of India. The Centre has been set up in collaboration with the Biotechnology Industry Research Assistance Council (BIRAC) at Syngene's campus in Bengaluru and will host a GLP accredited analytical laboratory. Regulatory approval of complex biological molecules involves extensive and advanced analytics including assessment of physiochemical characteristics, efficacy, immunogenicity (antidrug antibody), contamination, strength and more. All these tests need to be performed in a GLP compliant analytical facility. Availability of appropriate certified facilities at affordable costs is a challenge that the start-ups, SMEs/MMEs and the academia in India, have too often face. CAPS will help address this challenge and will be a big boost in advancing biopharma research and product development in India. Spread across an area of 2,000 sq. ft., the Centre will run under the `Innovate in India' program of the National Biopharma Mission, Department of Biotechnology, announced by the Government of India.